Share-based Payment Arrangement, Expense of Renalytix plc from 30 Jun 2019 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Renalytix plc quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2019 to 30 Sep 2024.
  • Renalytix plc Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2024 was $254,000, a 52% decline year-over-year.
  • Renalytix plc Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2024 was $1,440,000, a 47% decline year-over-year.
  • Renalytix plc annual Share-based Payment Arrangement, Expense for 2024 was $1,710,000, a 42% decline from 2023.
  • Renalytix plc annual Share-based Payment Arrangement, Expense for 2023 was $2,936,000, a 36% decline from 2022.
  • Renalytix plc annual Share-based Payment Arrangement, Expense for 2022 was $4,621,000, a 79% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Renalytix plc Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $1,440,000 $254,000 -$270,000 -52% 01 Jul 2024 30 Sep 2024 10-Q 19 Nov 2024 2025 Q1
Q2 2024 $1,710,000 $416,000 -$172,000 -29% 01 Apr 2024 30 Jun 2024 10-K 30 Sep 2024 2024 FY
Q1 2024 $1,882,000 $385,000 -$385,000 -50% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024 2024 Q3
Q4 2023 $2,267,000 $385,000 -$430,000 -53% 01 Oct 2023 31 Dec 2023 10-Q 14 Feb 2024 2024 Q2
Q3 2023 $2,697,000 $524,000 -$239,000 -31% 01 Jul 2023 30 Sep 2023 10-Q 19 Nov 2024 2025 Q1
Q2 2023 $2,936,000 $588,000 -$1,223,000 -68% 01 Apr 2023 30 Jun 2023 10-K 30 Sep 2024 2024 FY
Q1 2023 $4,159,000 $770,000 -$153,000 -17% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q3
Q4 2022 $4,312,000 $815,000 -$98,000 -11% 01 Oct 2022 31 Dec 2022 10-Q 14 Feb 2024 2024 Q2
Q3 2022 $4,410,000 $763,000 -$211,000 -22% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2024 Q1
Q2 2022 $4,621,000 $1,811,000 01 Apr 2022 30 Jun 2022 10-K 28 Sep 2023 2023 FY
Q1 2022 $923,000 +$922,389 01 Jan 2022 31 Mar 2022 6-K 09 Jun 2023
Q4 2021 $913,000 +$411,000 +82% 01 Oct 2021 31 Dec 2021 6-K 30 Mar 2023
Q3 2021 $974,000 01 Jul 2021 30 Sep 2021 6-K 30 Nov 2022
Q1 2021 $611* 01 Jan 2021 31 Mar 2021 6-K 30 Jun 2022
Q4 2020 $502,000 01 Oct 2020 31 Dec 2020 6-K/A 29 Apr 2022

Renalytix plc Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,710,000 -$1,226,000 -42% 01 Jul 2023 30 Jun 2024 10-K 30 Sep 2024 2024 FY
2023 $2,936,000 -$1,685,000 -36% 01 Jul 2022 30 Jun 2023 10-K 30 Sep 2024 2024 FY
2022 $4,621,000 +$2,035,000 +79% 01 Jul 2021 30 Jun 2022 10-K 28 Sep 2023 2023 FY
2021 $2,586,000 +$1,427,000 +123% 01 Jul 2020 30 Jun 2021 20-F 31 Oct 2022 2022 FY
2020 $1,159,000 +$634,000 +121% 01 Jul 2019 30 Jun 2020 20-F 31 Oct 2022 2022 FY
2019 $525,000 01 Jul 2018 30 Jun 2019 20-F/A 01 Aug 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.